Related Experiment Video
Updated: Jun 2, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Vitamin D as a promising anticancer agent
1Department of Microbiology, Kanak Manjari Institute of Pharmaceutical Sciences, Rourkela, India.
Abstract:
Presence of vitamin D receptors in noncalcemic tissues and subsequent identification of its involvement in growth factor(s)-mediated cellular function suggested its probable beneficial role in genesis, progression and survival of cancerous growths. Data collected from both in vitro and in vivo studies are highly optimistic regarding its potential in prevention and regression of colorectal, prostate and breast cancers. The vitamin has been found to interfere with the transduction pathways of various growth factor(s)-activated receptors (receptor tyrosine kinases) thereby modulating transcription and alteration of genomic functions resulting in inhibition of cell proliferation and angiogenesis and facilitation of cell differentiation and apoptosis. It also increases the level of an endogenous protein - cystatin D, which possesses antitumor and antimetastatic property, by facilitation of the expression of the gene coding for it. Though not as a primary anticancer agent, this vitamin may be used for the prevention of cancer and included as an adjuvant in combination chemotherapy for the treatment of cancer.
Insights
Vitamin D shows promise in preventing and treating cancers like colorectal, prostate, and breast cancer. It works by inhibiting cancer cell growth and promoting cell death, acting as a valuable adjuvant therapy.
Area of Science:
- Oncology
- Molecular Biology
- Nutritional Science
Background:
- Vitamin D receptors are present in noncalcemic tissues.
- Vitamin D influences growth factor-mediated cellular functions.
- Potential role of vitamin D in cancer genesis, progression, and survival is suggested.
Purpose of the Study:
- To evaluate the potential of vitamin D in cancer prevention and regression.
- To investigate the mechanisms by which vitamin D affects cancer cells.
- To explore vitamin D's role as an adjuvant in cancer therapy.
Main Methods:
- In vitro and in vivo studies were conducted.
- Analysis of vitamin D's interference with growth factor receptor signaling pathways (receptor tyrosine kinases).
- Assessment of vitamin D's effect on gene expression, cell proliferation, angiogenesis, differentiation, and apoptosis.
Main Results:
- Optimistic data regarding vitamin D's potential in preventing and regressing colorectal, prostate, and breast cancers.
- Vitamin D interferes with receptor tyrosine kinase pathways, modulating transcription and genomic functions.
- Vitamin D inhibits cell proliferation and angiogenesis, while facilitating cell differentiation and apoptosis.
- Vitamin D upregulates cystatin D, an endogenous protein with antitumor and antimetastatic properties.
Conclusions:
- Vitamin D demonstrates significant potential in cancer prevention and as an adjuvant in cancer treatment.
- Its mechanisms involve modulating key cellular pathways, inhibiting tumor growth, and promoting cell death.
- Further research supports its inclusion in combination chemotherapy regimens for various cancers.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Inhibition of Cdk Activity
